BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3325290)

  • 1. A new approach to image subtraction in immunoscintigraphy: preliminary results.
    Liehn JC; Hannequin P; Nasca S; Lebrun D; Cattan A; Valeyre J
    Eur J Nucl Med; 1987; 13(8):391-6. PubMed ID: 3325290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
    Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
    Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging of colo-rectal carcinoma with an anti-CEA monoclonal antibody.
    Gasparini M; Ripamonti M; Seregni E; Regalia E; Buraggi GL
    Int J Cancer Suppl; 1988; 2():81-4. PubMed ID: 3162449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical approach for the reduction of dual radionuclide image subtraction artefacts in immunoscintigraphy.
    Perkins AC; Whalley DR; Hardy JG
    Nucl Med Commun; 1984 Aug; 5(8):501-12. PubMed ID: 6398411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of radio-labelled monoclonal antibodies for the scintigraphic detection of human colorectal cancers].
    Chatal JF; Bourdoiseau M; Fumoleau P; Douillard JY; Kremer M; Curtet C; Le Mevel B
    Bull Cancer; 1983; 70(2):103-7. PubMed ID: 6871485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer.
    Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG
    Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy of colon carcinoma.
    Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H
    J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between 131I and 111In as radiolabels for monoclonal antibodies in immunoscintigraphy of tumor bearing nude mice.
    Thedrez P; Blottiere H; Chatal JF; Grzyb J; Douillard JY
    Tumour Biol; 1986; 7(2-3):137-45. PubMed ID: 3797961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
    Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
    Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36).
    Armitage NC; Perkins AC; Pimm MV; Wastie ML; Baldwin RW; Hardcastle JD
    Nucl Med Commun; 1985 Oct; 6(10):623-31. PubMed ID: 3867028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of immunoscintigraphy in the follow-up of surgically treated gastrointestinal carcinomas using 111In-labelled anti-CEA monoclonal antibodies.
    Cimitan M; Boz G; Spaziante R; Sorce P; De Paoli A; Baldoncini A; Borsatti E; Trovò MG; Zecchin R
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):368-72. PubMed ID: 1463689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoscintigraphy or intraoperative isotopic detection of colorectal neoplastic lesions using labelled monoclonal antibodies. Preliminary study. 20 cases].
    Proye C; Carnaille B; Sautier M; Verin P; Triboulet JP; Foucher-Hossein C; Marchandise X
    Chirurgie; 1989; 115(9):640-5. PubMed ID: 2642153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method.
    Liehn JC; Hannequin P; Nasca S; Lebrun D; Fernandez-Valoni A; Valeyre J
    Clin Nucl Med; 1989 Mar; 14(3):187-91. PubMed ID: 2736845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.
    Pimm MV; Perkins AC; Armitage NC; Baldwin RW
    J Nucl Med; 1985 Sep; 26(9):1011-23. PubMed ID: 3861794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal immunoscintigraphy for the detection of primary colorectal cancers: a prospective study.
    Finan PJ; Ritson A; Ware F; Parkin A; Robinson PJ; Sikora K; Giles GR
    Br J Surg; 1986 Mar; 73(3):177-9. PubMed ID: 3947915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.
    Farrands PA; Perkins AC; Pimm MV; Embleton MJ; Hardy JD; Baldwin RW; Hardcastle JD
    Lancet; 1982 Aug; 2(8295):397-400. PubMed ID: 6124802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
    Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
    Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
    Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
    Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.